IndiaRF begins $250-300M stake sale in Synthimed Labs
India Resurgence Fund has launched a process to sell a minority stake in API maker Synthimed Labs, targeting a $1 billion valuation. Read the full details on the deal and the company's growth.
India Resurgence Fund has launched a process to sell a minority stake in API maker Synthimed Labs, targeting a $1 billion valuation. Read the full details on the deal and the company's growth.
India Resurgence Fund acquires a 51% controlling stake in Shree Digvijay Cement from True North, marking its strategic entry into India's cement industry. Read the full deal details.